atopica logo

ATOPICA® (cyclosporine capsules) USP MODIFIED

Bronchi-Shield® ORAL

Captar Logo

Capstar® (nitenpyram)

Clomicalm Logo 4C 2016

Clomicalm® (clomipramine hydrochloride)

Comfortis Logo

Comfortis® (spinosad)

Credelio® (lotilaner)

Deramaxx logo

Deramaxx® (deracoxib)

Galliprant Logo

Galliprant® (grapiprant tablets)

Interceptor® (milbemycin oxime)

Interceptor Plus Logo

Interceptor® Plus (milbemycin oxime/praziquantel)

Onsior logo

Onsior® Tablets for Dogs (robenacoxib)

onsior logo

Onsior® Injection (robenacoxib)

Osurnia® (florfenicol, terbinafine, betamethasone acetate)

PARASTAR Logo

Parastar® for Dogs

ParastarPLUS Logo

Parastar® Plus (fipronil/cyphenothrin)

Percorten-V Logo

Percorten®-V (desoxycorticosterone pivalate injectable suspension)

Placeholder until correct image

Rabvac®

Surolan Logo

Surolan® (miconazole nitrate, polymyxin B sulfate, prednisolone acetate)

Trifexis logo

Trifexis® (spinosad + milbemycin oxime)

Ultra Duramune logo

ULTRA™ Duramune®

Vetspon logo

Vetspon

Zobuxa logo

Zobuxa® (enrofloxacin)


Bronchi-Shield® ORAL

They Don't Call It the "Happy Vaccine Experience" for nothing.

NO INITIAL BOOSTER. NO NEEDLES. NO SNEEZE-BACKS. NO WRESTLING.

Bronchi-Shield ORAL offers fast, one-and-done protection* against Bordetella, a common cause of Canine Infectious Respiratory Disease (CIRD).

Bronchi-Shield ORAL was the first modified-live avirulent Bordetella bronchiseptica vaccine licensed for oral administration. Additionally, it’s easy to administer for mucosal delivery and has been proven effective in a published, peer-reviewed challenge study.1

This revolutionary vaccine:

  • Provides a convenient and comfortable experience for dogs
  • Is proven 93% effective1
  • Offers fast onset of immunity1
BronchiShield-lll TM logo 4C

GET BROAD CIRD COVERAGE WITH BRONCHI-SHIELD III

Bronchi-Shield III, the first line of defense against three antigens involved in CIRD, is designed for intranasal immunization against Bordetella bronchiseptica, canine parainfluenza virus and canine adenovirus type 2.
A research study evaluating the efficacy of Bronchi-Shield III found that none of the vaccinates coughed while 100% of control dogs coughed following a Bordetella bronchiseptica challenge.2

Bronchi-Shield III provides fast, effective immunity against three diseases2

11347 Bronchi-Shield Product HR CHART A

Always read, understand and follow the label and use directions.

Bronchi-Shield, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

*For initial vaccination, only one dose is required.

  1. Hess, T., Parker, D., et al. (2011). Evaluation of efficacy of oral administration of Bordetella bronchiseptica     intranasal vaccine when used to protect puppies from tracheobronchitis due to B. bronchiseptica     infection. Intern J Appl Res Vet Med, 9(3), 300-305.
  2. Elanco Animal Health. Data on file.